Do diabetes medications like Mounjaro affect CAR-T cell effectiveness?

Nerdy scientific question - FOXO1, insulin, CAR-T FOXO1 plays role in insulin regulation and T cell function. If I’m reading things right, inhibiting FOXO1 improves diabetes, but here’s where I get confused, inhibiting it can promote exhaustion and reduce memory of CAR-T cells. So, if I’m understanding it right, and I may be completely wrong, people taking GLP-1 and GIP (like in Mounjaro) might be hurting their CAR-T cells. (Other diabetes drugs too) Am I understanding it backwards? Hard to believe it would actually harm CAT-T cells. Some things I read say they work together to enhance, but some deep stuff I’ve read would suggest the opposite. The Dual Role: The transcription factor FOXO1 holds a paradoxical role. While its elevated activity is beneficial for T cell-mediated immunotherapy, it is detrimental to glucose homeostasis. Yet GLP-1 agonists (like semaglutide) are being used to "supercharge" CAR T-cells by improving their energy and endurance against cancer. So which is it?